The vaccine against Covid-19 developed by the British laboratory AstraZeneca and the University of Oxford is 70% effective on average, according to a statement released Monday.
Read also: Covid-19: "The duration of protection of vaccines is a major unknown"
These are interim results from large-scale clinical trials in the UK and Brazil, says AstraZeneca.
This vaccine is currently less convincing than that of Pfizer and BioNTech or Moderna, whose effectiveness exceeds 90%.